尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Savill Corrine, Responsable par Intérim des Affaires Commerciales. Insider active across 2 companies, notably Cullinan Oncology, Inc.. Cumulatively, 10 disclosures have been logged. Split: 0 buy · 3 sells. Total volume traded: €606k. Activity tracked since 11 February 2022. The latest transaction was filed on 19 February 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Savill Corrine is Responsable par Intérim des Affaires Commerciales and has made 10 filings in total. In the 10 most recent filings we hold, they cover the period from 2022-02-15 to 2025-02-21, with EUR 0 of buys and EUR 605627 of sells, mainly related to Cullinan Oncology, Inc. and Cullinan Therapeutics, Inc.